Consun Pharmaceutical Group Limited (1681.HK)

HKD 9.64

(4.1%)

Net Income Summary of Consun Pharmaceutical Group Limited

  • Consun Pharmaceutical Group Limited's latest annual net income in 2023 was 784.53 Million CNY , up 14.88% from previous year.
  • Consun Pharmaceutical Group Limited's latest quarterly net income in 2024 Q2 was 399.76 Million CNY , down 0.0% from previous quarter.
  • Consun Pharmaceutical Group Limited reported an annual net income of 682.9 Million CNY in 2022, up 15.71% from previous year.
  • Consun Pharmaceutical Group Limited reported an annual net income of 590.17 Million CNY in 2021, up 18.32% from previous year.
  • Consun Pharmaceutical Group Limited reported a quarterly net income of 784.53 Million CNY for 2023 FY, up 14.88% from previous quarter.
  • Consun Pharmaceutical Group Limited reported a quarterly net income of 436.64 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Consun Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Net Income of Consun Pharmaceutical Group Limited (2023 - 2012)

Year Net Income Net Income Growth
2023 784.53 Million CNY 14.88%
2022 682.9 Million CNY 15.71%
2021 590.17 Million CNY 18.32%
2020 498.78 Million CNY 524.89%
2019 79.82 Million CNY -82.85%
2018 465.35 Million CNY 17.44%
2017 396.24 Million CNY 28.85%
2016 307.52 Million CNY 23.16%
2015 249.68 Million CNY 18.22%
2014 211.2 Million CNY 38.15%
2013 152.88 Million CNY 12.24%
2012 136.2 Million CNY 0.0%

Peer Net Income Comparison of Consun Pharmaceutical Group Limited

Name Net Income Net Income Difference
Pak Fah Yeow International Limited 105.03 Million HKD -646.898%
Grand Pharmaceutical Group Limited 1.87 Billion HKD 58.269%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 581.46%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 5208.974%
Qianhai Health Holdings Limited -52.7 Million HKD 1588.538%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -4598.371%
Essex Bio-Technology Limited 275.25 Million HKD -185.016%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 2820.015%
PuraPharm Corporation Limited -106.08 Million HKD 839.561%
SSY Group Limited 1.31 Billion HKD 40.503%
JBM (Healthcare) Limited 130.46 Million HKD -501.346%
Jacobson Pharma Corporation Limited 266.96 Million HKD -193.868%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 79.645%